[Testicular tumors--a current review]

Area of Science:

• Urology
• Oncology
• Men's Health

Context:

• Testicular cancer represents 1% of male tumors but is the most frequent neoplasia in younger men.
• Key risk factors include cryptorchidism and a personal history of testicular cancer.
• It is primarily categorized into germ cell and non-germ cell types, with germ cell cancers further divided into seminomas and non-seminomas.

Purpose:

• To outline the epidemiology, risk factors, and clinical presentation of testicular cancer.
• To describe the diagnostic pathway, including ultrasonography and tumor marker analysis.
• To detail the primary treatment modalities and staging-dependent therapeutic strategies.

Summary:

• Painless swelling is the typical initial clinical presentation.
• Diagnosis involves ultrasonography and tumor marker analysis, followed by radical inguinal orchiectomy as the initial therapeutic step.
• Treatment options include surveillance, radiotherapy, and chemotherapy, tailored to the cancer's stage.

Impact:

• Testicular cancer demonstrates excellent cure rates, ranging from 98-100% in early stages.
• High recurrence-free survival rates (80-90%) are achievable even in advanced stages.
• Highlights the importance of timely diagnosis and treatment for favorable patient outcomes.